The kits help to generate specific neural cell types without sacrificing cell purity.
Biotechnology company Amsbio has released a range of induced pluripotent stem cell (iPSC) kits for researchers to generate specific neural cell types without sacrificing cell purity.
With these kits, scientists can produce neurons as needed and efficiently differentiate iPSCs into target neutral cells within two weeks.
Reproducible protocols ensure experimental consistency despite the flexibility in design of disease modelling, regenerative medicine and drug experiments.
The kits produce differentiated cells with no genetic footprint left behind, via a proprietary non-integrating transcription factor-based approach.
Users can choose from Sendai virus, synthetic mRNA formats or one of the diseased. Alternatively, diseased and control cell lines that have already been differentiated are available for several neural cell types.
The range includes a variety of kits which support the production and differentiation of different neurons. This includes the Quick-Neuron Excitatory differentiation kit, Dopaminergic differentiation kit, GABAergic differentiation kit and Cholinergic differentiation kit.
